Ginkgo biloba Extract: Review of CNS Effects

Annals of Clinical Psychiatry

Volumn 15, Issue 2, 2003, Pages 109-119

  Boles Ponto, Laura L ^a,b   Schultz, Susan K ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Aging; EGb 761; Ginkgo biloba extract

Indexed keywords

ACETYLSALICYLIC ACID; CHOLINESTERASE INHIBITOR; DONEPEZIL; FLAVONE DERIVATIVE; FLAVONOID; GINKGO BILOBA EXTRACT; GINKOBA; GLYCOSIDE; ISORHAMNETIN; KAEMPFEROL; METRIFONATE; NONSTEROID ANTIINFLAMMATORY AGENT; QUERCETIN DERIVATIVE; RIVASTIGMINE; TACRINE; TERPENE DERIVATIVE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTERY OCCLUSION; BLEEDING; BLOOD FLOW; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN METABOLISM; COGNITIVE DEFECT; DIZZINESS; DOSE RESPONSE; DRUG ACTIVITY; DRUG ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DYSPEPSIA; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; GINKGO BILOBA; GINSENG; HEADACHE; HEMATOMA; HUMAN; HYPERSENSITIVITY; HYPHEMA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOMNOLENCE;

ANIMALS; BRAIN; CLINICAL TRIALS; DEMENTIA; GINKGO BILOBA; HUMANS; NEUROPROTECTIVE AGENTS; PLANT EXTRACTS;

EID: 0345871329     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024688326023     Document Type: Review

References (86)

1. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA: Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA 2002; 287(3):337-344
2. Anonymous: PDR for Herbal Medicines: Ginkgo biloba. 1st edn. Montvale, NJ: Medical Economics Co; 1998:871-873
3. Tyler VE: The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, 3rd edn. New York: Pharmaceutical Products Press; 1993:149-151
4. Wincor MZ: Ginkgo biloba for dementia: A reasonable alternative? JAPhA 1999; 39(3):415-416
5. Chen C, Wei T, Gao Z, Zhao B, Hou J, Xu H, Xin W, Packer L: Different effect of the constituents of EGb761 on apoptosis in rat cerebellar granual cells induced by hydroxyl radicals. Biochem Mol Biol Int 1999; 47(3):397-405
6. Bedir E, Tatli II, Khan RA, Zhao J, Takamatsu S, Walker LA, Goldman P, Khan IA: Biologically active secondary metabolites from Ginkgo biloba. J Agric Food Chem 2002; 50:3150-3155
7. Sasaki K, Oota I, Wada K, Inomata K, Ohshika H, Haga M: Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices. Comp Biochem Physiol C 1999; 124:315-321
8. Sasaki K, Hatta S, Haga M, Ohshika H: Effects of bilobalide on γ-aminobutyric acid levels and glutamic acide decarboxylase in mouse brain. Eur J Pharmacol 1999; 367:165-173
9. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Drieu K, Fiskum G: Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res 2001; 922:282-292
10. Lenoir M, Pedruzzi E, Rais S, Drieu K, Perianin A: Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761. Biochem Pharmacol 2002; 63:1241-1249
11. Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PKT, Coutts RT: Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves. J Pharm Pharmacol 2000; 52:451-459
12. McKenna DJ, Jones K, Hughes K: Efficacy, safety, and use of Ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001; 7(5):70-90
13. Youdim KA, Joseph JA: A possible emerging role of phytochemicals in improving age-related neurological dysfunction: A multiplicity of effects. Free Radical Biol Med 2001; 30(6):583-594
14. Alaoui-Youssefi A, Lamproglou I, Drieu K, Emerit I: Anticlastogenic effects of Ginkgo biloba extract (EGb 761) and some of its constituents in irradiated rats. Mutat Res 1999; 445:99-104
15. Nathan P: Can the cognitive enhancing effects of Ginkgo biloba be explained by its pharmacology? Med Hypotheses 2000; 55(6):491-493
16. LeBars PL, Kieser M, Itil KZ: A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 2000; 11:230-237
17. Blumenthal M, Busse WR, Goldberg A, Gruenwald J, Hall T, Riggins CW, Rister RS, eds.: The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998:136-138
18. Klepser TB, Klepser ME: Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999; 56:125-138
19. Kleijnen J, Knipschild P: Ginkgo biloba. Lancet 1992; 340:1136-1139
20. Chavez ML, Chavez PI: Ginkgo (Part 2): Clinical efficacy, dosage, and adverse effects. Hosp Pharm 1998; 33(9):1076-1095
21. Vaes LPJ, Chyka PA: Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: Nature of the evidence. Ann Pharmacotherapy 2000; 34:1478-1482
22. Miller LG: Herbal medicines. Arch Intern Med 1998; 158(9):2200-2211
23. Fugh-Berman A: Herb-drug interactions. Lancet 2000; 355:134-138
24. Maclennan KM, Darlington CL, Smith PF: The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiology 2002; 67:235-257
25. Gohil K: Genomic responses to herbal extracts: lessons from in vitro and in vivo studies with an extract of Ginkgo biloba. Biochem Pharmacol 2002; 64:913-917
26. Itil TM, Eralp E, Tsambis E, Itil KZ, Stein U: Central nervous system effects of Ginkgo biloba, a plant extract. Am J Therap 1996; 3:63-73
27. Itil T, Martorano D: Natural substances in psychiatry (Ginkgo biloba in dementia). Psychopharmcol Bull 1995; 31(1):147-158
28. Rigney U, Kimber S, Hindmarch I: The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother Res 1999; 13:408-415
29. Allain H, Raoul P, Lieury A, LeCoz F, Gandon JM: Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993; 15:549-558
30. Sudhon Z, Hindmarch I: The pharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharmacol Res 1984; 4(2):89-93
31. Hindmarch SZ: The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharm Res 1984; IV:89-93
32. Kennedy DO, Scholey AB, Wesnes KA: The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology 2000; 151:416-423
33. Kennedy DO, Scholey AB, Wesnes KA: Differential, dose dependent changes in cognitive performance following acute administration of a Ginkgo biloba/ Panax ginseng combination to healthy young volunteers. Nutr Neurosci 2001; 4:399-412
34. Wesnes KA, Ward T, McGinty A, Petrini O: The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000; 152:353-361
35. Mix JA, Crews WD: An examination of the efficacy of Ginkgo biloba extract EGB 761 on the nueropsychologic functioning of cognitively intact older adults. J Altern Complementary Med 2000; 6(3):219-229
36. Stough C, Clarke J, Lloyd J, Nathan PJ: Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. Int J Neuropsychopharmacol 2001; 4:131-134
37. Moulton PL, Boyko LN, Fitzpatrick JL, Petros TV: The effect of Ginkgo biloba on memory in healthy male volunteers. Physiol Behav 2001; 73:659-665
38. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R: Ginkgo for memory enhancement: A randomized controlled trial. JAMA 2002; 288(7):835-840
39. Ernst E, Pittler MH: Ginkgo biloba for dementia: A systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17(4):301-308
40. Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R: Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of alzheimer type or multi-infarct dementia. Pharmacopsychiatria 1996; 29:47-56
41. Maurer K, Ihl R, Dierks T, Frolich L: Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 1997; 31(6):645-655
42. Winther K, Randlov C, Rein E, Mehlsen J: Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Curr Therap Res 1998; 59(12):881-888
43. LeBars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg A: A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278:1327-1332
44. Wettstein A: Cholinesterase inhibitors and Ginkgo extracts - are they comparable in the treatment of dementia? Phytomedicine 2000; 6(6):393-401
45. Curtis-Prior C, Vere D, Fray P: Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function. J Pharm Pharmacol 1999; 51:535-541
46. LeBars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R: Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGB 761® in Alzheimer's disease. Neuropsychobiology 2002; 45:19-26
47. Van Dongen MCJM, van Rossum E, Kessels AGH, Sielhorst HJG, Knipschild PG: The efficacy of Ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000; 48:1183-1194
48. Agnoli A, Fiorani P, Pistolese GR: Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of Ginkgo biloba. Minerva Med 1973; 64(79 Suppl):4166-4173
49. Barker PB, Yousem DM: Reproducibility of MR perfusion imaging with GdDTPA: Effect of Ginkgo biloba. Proc Intl Soc Mag Reson Med 2000; 8:1272
50. Andreasen NC, O'Leary DS, Cizadlo T, Arndt S, Rezai K, Watkins GL, Ponto LLB, Hichwa RD: II. PET studies of memory: Novel versus practiced free recall of word lists. Neuroimage 1995; 2:296-305
51. Schweizer J, Hautmann C: Comparison of two dosages of Ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's Stage IIb. Arzneim-Forsch/Drug Res 1999; 49(II):900-904
52. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R: Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Therap 1999; 15(3):233-240
53. Krieglstein J, Beck T, Seibert A: Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 1986; 39:2327-2334
54. Zhang WR, Hayashi T, Kitagawa H, Sasaki C, Sakai K, Warita H, Wang JM, Shiro Y, Uchida M, Abe K: Protective effect of Ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol Res 2000; 22:517-521
55. Rapin JR, Lafitte ML: Local cerebral glucose consumption: Effects of Ginkgo biloba extract. La Presse Medicale 1986; 15(31):1494-1497
56. Loffler T, Lee SK, Noldner M, Chatterjee SS, Hoyer S, Schliebs R: Effect of Ginkgo biloba extract (EGb761) on glucose metabolism-related markers in streptozotocin-damaged rat brains. J Neural Transm 2001; 108:1457-1474
57. Duverger D, Defeudis FV, Drieu K: Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) on cerebral glucose utilization in the rat: an autoradiographic study. Gen Pharac 1995; 26(6):1375-1383
58. Janssens D, Michiels C, Guillaume G, Cuisinier B, Louagie Y, Remacle J: Increase in circulating endothelial cells in patients with primary chronic venous insufficiency: Protective effect of Ginkor Fort in a randomized double-blind, placebo-controlled clinical trial. J Cardiovasc Pharmacol 1999; 33:7-11
59. Kurtsoy A, Canbay S, Oktem IS, Akdemir H, Koc RK, Menku A, Tucer B: Effect of EGb-761 on vasospasm in experimental subarachnoid hemorrhage. Res Exp Med 2000; 199:207-215
60. Cheung F, Siow YL, Chen WZ, Karmin O: Inhibitory effect of Ginkgo biloba extract on the expression of inducible nitric oxide synthase in endothelial cells. Biochem Pharmacology 1999; 58:1665-1673
61. Varga E, Bodi A, Ferninandy P, Droy-Lefaiz MT, Blasig IE, Tosaki A: The protective effect of EGb 761 in isolated ischemic/reperfused rat hearts: A link between cardiac function and nitric oxide production. J Cardiovascular Pharmacol 1999; 34:711-717
62. Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM: Ginkgo biloba extract (EGb 761) protects Na, K-ATPase activity during cerebral ischemia in mice. NeuroReport 1999; 10:47-51
63. Wei T, Ni Y, Hou J, Chen C, Zhao B, Xin W: Hydrogen peroxide-induced oxidative damage and apoptosis in cerebellar granule cells: Protection by ginkgo biloba extract. Pharmacol Res 2000; 41(4):427-433
64. Wei Z, Peng Q, Lau BHS, Shah V: Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. Gen Pharmacol 1999; 33:369-375
65. Welt K, Weiss J, Koch S, Fitzl G: Protective effects of Ginkgo biloba extract EGb 761 on the myocaridum of experiemtnally diabetic rats. Exp Toxic Pathol 1999; 51:213-222
66. Punkt K, Psinia I, Welt K, Barth W, Asmussen G: Effects on skeletal muscle fibres of diabetes and Ginkgo biloba extract treatment. Acta histochem 1999; 101:53-69
67. Du G, Willet K, Mouithys-Michalad A, Sluse-Goffart CM, Droy-Lefaix MT, Sluse FE: EGb 761 protects liver mitochondria against injury induced by in vitro anoxia/reoxygenation. Free Radical Biol Med 1999; 27(5/6):596-604
68. Janssens D, Remacle J, Drieu K, Michiels C: Protection of mitochondrial respiration activity by bilobalide. Biochem Pharmacol 1999; 58:109-119
69. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA: Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 2002; 70:357-360
70. Schindowski K, Leutner S, Kressmann S, Eckert A, Muller WE: Age-related increase of oxidative stress-induced apoptosis in mice: Prevention by Ginkgo biloba extract (EGb761). J Neural Transm 2001; 108:969-978
71. Trovero F, Brochet D, Tassin JP, Drieu K: Ginkgo biloba extract EGb761 reduces the development of amphetamine-induced behavioral sensitization: effects on hippocampal type II corticosteroid receptors. Brain Res 1999; 818:135-139
72. 2 activation and phospholipid breakdown in rat hippocampus. Nauyn-Schmiedeberg's Arch Pharmacol 1999; 360:609-615
73. Bastianetto S, Zheng WH, Quirion R: The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase C. J Neurochem 2000; 74:2268-2277
74. Calapai G, Crupi A, Firenzuoli F, Marciano MC, Squadrito F, Inferrera G, Parisi A, Rizzo A, Crisafulli C, Fiore A, Caputi AP: Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 2000; 67:2673-2683
75. Yao ZX, Drieu K, Szweda LI, Papadopoulos V: Free radical and lipid peroxidation do not mediate β-amyloid-induced neuronal cell death. Brain Res 1999; 847:203-210
76. Yao Zx, Drieu K, Papadopoulos V: The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β amyloid-induced cell death by inhibiting the formation of β amyloid-derived diffusible neurotoxic ligands. Brain Res 2001; 889:181-190
77. Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R: The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β amyloid. Eur J Neurosci 2000; 12:1882-1890
78. Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, Khan I, Netzer WJ, Xu H, Butko P: Inhibition of amyloid-b aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. PNAS 2002; 99(19):12197-12202
79. Gajewski A, Hensch SA: Ginkgo biloba and memory for a maze. Psychol Rep 1999; 84:481-484
80. Wirth S, Stemmelin J, Will B, Christen Y, Di Scala G: Facilitative effects of EGb 761 on olfactory recognition in young and aged rats. Pharmacol Biochem Behav 2000; 65(2):321-326
81. Winter JC, Timineri D: The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol Biochem Behav 1999; 62(3):543-547
82. Wu WR, Zhu XZ: Involvement of monamine oxidase inhibition in neuroprotective and neurorestorative effect of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 1999; 65(2):157-164
83. Pardon MC, Joubert C, Perez-Diaz F, Christen Y, Launay JM, Cohen-Salmon C: In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761). Mech Ageing Dev 2000; 113:157-168
84. Porsolt RD, Roux S, Drieu K: Evaluation of a Ginkgo biloba extract (EGb 761) in functional tests for monamine oxidase inhibition. Arzneim-Forsch/Drug Res 2000; 50(I):232-235
85. Fowler JS, Wang G-J, Volkow ND, Logan J, Franceschi D, Franceschi M, MacGregor R, Shea C, Garza V, Liu N, Ding YS: Evidence that Ginkgo biloba extract does not inhibit MAO A and B in living human brain. Life Sci 2000; 66(9):141-146
86. Larrabee GJ, McEntee WJ: Age associated memory impairment: Sorting out the controversies. Neurology 1995; 45:611-614